OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.530
-0.020 (-0.78%)
At close: May 30, 2025, 4:00 PM
2.450
-0.080 (-3.16%)
After-hours: May 30, 2025, 5:52 PM EDT

OnKure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-59.06-52.67-35.31-29.51
Depreciation & Amortization
0.720.660.560.39
Other Amortization
0.140.14--
Loss (Gain) From Sale of Investments
0.050.05--
Stock-Based Compensation
7.174.530.20.05
Other Operating Activities
0.120.12--
Change in Accounts Payable
-5.87-5.931.712.65
Change in Other Net Operating Assets
2.231.98-1.71-0.53
Operating Cash Flow
-54.49-51.12-34.55-26.95
Capital Expenditures
-0.06-0.05-0.25-1.13
Investment in Securities
15.9315.93--
Investing Cash Flow
15.8615.87-0.25-1.13
Long-Term Debt Issued
-6--
Net Debt Issued (Repaid)
66--
Issuance of Common Stock
58.958.910.070.34
Other Financing Activities
51.1551.22-0.72-1.38
Financing Cash Flow
116.04116.1353.1326.47
Net Cash Flow
77.4180.8918.33-1.62
Free Cash Flow
-54.55-51.17-34.79-28.09
Free Cash Flow Per Share
-8.11-14.84-122.59-
Levered Free Cash Flow
-25.21-23.71-22.69-
Unlevered Free Cash Flow
-25.26-23.76-22.69-
Change in Net Working Capital
-4.85-4.570.12-
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q